Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty
- 15 May 1992
- journal article
- case report
- Published by Elsevier in The American Journal of Cardiology
- Vol. 69 (16), 1373-1376
- https://doi.org/10.1016/0002-9149(92)91242-v
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe anginaJournal of the American College of Cardiology, 1991
- Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibodyJournal of the American College of Cardiology, 1990
- Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.Circulation, 1990
- Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris.JCI Insight, 1990
- Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and type of acute complications of percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1990
- Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.JCI Insight, 1988